Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access: APRN
      • NetCE All Access: MD
      • NetCE All Access: PA
      • NetCE All Access: RN
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights: APRN
      • Prescriber Insights: MD
      • Prescriber Insights: PA
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • Natural Medicines Resources
  • Drug Charts
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes

Diabetes

  • Diabetes (649)
    • Blood Glucose Meters (3)
    • Complications (177)
    • Diabetes in Pregnancy (14)
    • Diabetes Meds (68)
    • Drug-Induced Hypo/Hyperglycemia (133)
    • Monitoring (121)
    • Natural Medicines/Supplements (14)
    • Prevention (56)
    • Treatment (323)
  • Endocrinology (12)
  • Hyperglycemia (27)
  • Hypoglycemia (28)
  • Other (26)
  • Prediabetes (5)
  • Resources (221)
  • Thyroid Disorders (49)
106 - 120 of 649 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Compare Cardiovascular Benefits of SGLT2 Inhibitors for Type 2 Diabetes January 2019
Chart: Antihypertensive Combinations January 2019
Article: Evaluate Risks Before Recommending a Flozin November 2018
Article: Know Where Basal Insulin Combo Products Fit In to Diabetes Management October 2018
PL Voices: Diabetes Meds and Renal Protection September 2018
Article: Expect to Hear About Renal Protection With Flozins and GLP-1 Agonists September 2018
Chart: Angiotensin Receptor Blocker (ARB) Antihypertensive Dose Comparison September 2018
Chart: Common Cardiovascular Risk Calculators September 2018
Chart: Adverse Reactions With Systemic Quinolones September 2018
FAQ: Management of Albuminuria: Focus on Pharmacotherapy September 2018
Technician Tutorial: Hypertension 101 August 2018
PL Voices: Combining Flozins and GLP-1 Agonists July 2018
Article: Don't Recommend a Flozin Plus GLP-1 Agonist for Most Diabetes Patients July 2018
Patient Education: Aspirin and Your Heart July 2018
Chart: Combination Therapy with a GLP-1 Agonist July 2018
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved